Potential Treatment for Hemophilia
Researchers have discovered a novel treatment for human hemophilia and a broad range of other bleeding problems.
Researchers have discovered a novel treatment for human hemophilia and a broad range of other bleeding problems.
Dr. Bashi, said, “The patient came in with a large aneurysm of the ascending aorta, and a leak in the aortic valve. This procedure needs an open heart surgery, but with haemophilia, even the smallest mistake can cause the patient to bleed to death.”
A team of six specialists performed a seven-hour surgery. The aorta was replaced with a permanent Dacron graft made of synthetic material because metal or titanium grafts have to be replaced after 10 to 12 years.
Hemophilia in Animals Corrected by Genome Editing
Scientists have treated the blood clotting disorder hemophilia in mice by using an innovative gene therapy technique called genome editing
Scientists have treated the blood clotting disorder hemophilia in mice by using an innovative gene therapy technique called genome editing
The patient was injected with 2,200 units of anti-hemophilic drug two hours before the surgery. During the surgery, 7,000 units of anti-hemophilic drug were administered every hour to address the issue of blood not clotting.
Advertisement
Trial of Gene Therapy Treatment of Hemophilia B Shows Promise
Four hemophilia B patients in a gene therapy trial using a vector that is being developed to correct the inherited bleeding disorder have shown no toxicity,report investigators.
Four hemophilia B patients in a gene therapy trial using a vector that is being developed to correct the inherited bleeding disorder have shown no toxicity,report investigators.
Advertisement
FDA Starts Review of Biogen�s Therapy for Hemophilia B
The US Food and Drug Administration is currently reviewing Biogen Idec’s application for a fusion protein therapy.
The US Food and Drug Administration is currently reviewing Biogen Idec’s application for a fusion protein therapy.
Source-Medindia
